SG10201503541WA - Method for purifying a fused pyrrolocarbazole derivative - Google Patents

Method for purifying a fused pyrrolocarbazole derivative

Info

Publication number
SG10201503541WA
SG10201503541WA SG10201503541WA SG10201503541WA SG10201503541WA SG 10201503541W A SG10201503541W A SG 10201503541WA SG 10201503541W A SG10201503541W A SG 10201503541WA SG 10201503541W A SG10201503541W A SG 10201503541WA SG 10201503541W A SG10201503541W A SG 10201503541WA
Authority
SG
Singapore
Prior art keywords
purifying
fused pyrrolocarbazole
pyrrolocarbazole derivative
derivative
fused
Prior art date
Application number
SG10201503541WA
Other languages
English (en)
Inventor
Shawn P Allwein
Arnaud Grandeury
Guy Piacenza
Sébastien Rose
Original Assignee
Cephalon Inc
Teva Santé
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc, Teva Santé filed Critical Cephalon Inc
Publication of SG10201503541WA publication Critical patent/SG10201503541WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG10201503541WA 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative SG10201503541WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34583110P 2010-05-18 2010-05-18

Publications (1)

Publication Number Publication Date
SG10201503541WA true SG10201503541WA (en) 2015-06-29

Family

ID=44168420

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201503541WA SG10201503541WA (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative
SG2012084851A SG185645A1 (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012084851A SG185645A1 (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Country Status (20)

Country Link
US (1) US8884014B2 (enExample)
EP (1) EP2571885B1 (enExample)
JP (2) JP5828594B2 (enExample)
KR (1) KR101815332B1 (enExample)
CN (1) CN102958934B (enExample)
AU (1) AU2011256264B2 (enExample)
BR (1) BR112012029374B1 (enExample)
CA (1) CA2799517C (enExample)
CL (1) CL2012003208A1 (enExample)
EA (1) EA021869B1 (enExample)
ES (1) ES2530015T3 (enExample)
IL (2) IL223016A0 (enExample)
MX (1) MX2012013304A (enExample)
MY (1) MY156830A (enExample)
NZ (1) NZ604135A (enExample)
PH (1) PH12012502250A1 (enExample)
SG (2) SG10201503541WA (enExample)
UA (1) UA108498C2 (enExample)
WO (1) WO2011146488A1 (enExample)
ZA (1) ZA201209305B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965204B (zh) 2008-11-19 2016-09-07 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109229B2 (en) * 2000-09-29 2006-09-19 Eli Lilly And Company Methods and compounds for treating proliferative diseases
US7169802B2 (en) * 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
JP2006241579A (ja) 2005-03-07 2006-09-14 Nippon Paint Co Ltd 化成処理剤及び表面処理金属
CN103965204B (zh) * 2008-11-19 2016-09-07 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式

Also Published As

Publication number Publication date
IL242221A0 (en) 2015-11-30
BR112012029374A8 (pt) 2017-12-26
SG185645A1 (en) 2012-12-28
AU2011256264A1 (en) 2013-01-10
WO2011146488A1 (en) 2011-11-24
AU2011256264B2 (en) 2016-09-15
KR20140095116A (ko) 2014-08-01
UA108498C2 (en) 2015-05-12
CN102958934B (zh) 2015-06-17
BR112012029374B1 (pt) 2021-05-25
US20130123499A1 (en) 2013-05-16
JP2013526573A (ja) 2013-06-24
CN102958934A (zh) 2013-03-06
KR101815332B1 (ko) 2018-01-04
BR112012029374A2 (pt) 2016-07-26
JP5828594B2 (ja) 2015-12-09
ES2530015T3 (es) 2015-02-25
CA2799517A1 (en) 2011-11-24
EA201291269A1 (ru) 2013-05-30
HK1182100A1 (en) 2013-11-22
CA2799517C (en) 2019-01-22
ZA201209305B (en) 2014-02-26
PH12012502250A1 (en) 2013-02-04
IL242221B (en) 2018-06-28
IL223016A0 (en) 2013-02-03
CL2012003208A1 (es) 2013-05-17
NZ604135A (en) 2015-02-27
MY156830A (en) 2016-03-31
EA021869B1 (ru) 2015-09-30
MX2012013304A (es) 2013-04-03
EP2571885B1 (en) 2014-11-12
JP2016074668A (ja) 2016-05-12
US8884014B2 (en) 2014-11-11
EP2571885A1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
PT2612859E (pt) Método para a produzir o derivado de 1-triazole-2-butanol
SG11201403605PA (en) Method for separating gases
IL232558B (en) A method for antibody purification
ZA201202703B (en) Synthetic methods for spiro-oxindole compounds
ZA201202299B (en) Method for decreasing immunigenicity
IL223583A (en) A method for the production of quinoline-3-carboxamides
PL3470452T3 (pl) Sposób wytwarzania poliamidów odlewanych
EP2515174A4 (en) PROCESS FOR PREPARING A TONER
EP2743259B8 (en) Method for purifying (s)-oxiracetam
PL3202769T3 (pl) Sposoby oczyszczania związków fosfaplatyny
PT2649044T (pt) Método para síntese de derivados de aminociclo-hexanona substituídos
EP2653482A4 (en) PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE
EP2743258A4 (en) PROCESS FOR PURIFYING LEVO-OXIRACETAM
GB201105407D0 (en) Purification method
PL2476684T3 (pl) Sposób wytwarzania alkilofosforanów
PL2542327T3 (pl) Proces dla czyszczenia filtrów
ZA201400341B (en) Apparatus for creating a butt connection between tubular bodies
EP2791654A4 (en) METHOD FOR EXCITATION OF WAVELENGTH INCLUSION STRUCTURE
PT2635390E (pt) Método para fabricação de um rotor celular
PL2571887T3 (pl) Sposoby wytwarzania ditiino-tetrakarboksy-diimidów
GB2480639B (en) Suspension for a tricycle
IL242221A0 (en) A method for the purification of a fused pyrrolocarbazole derivative
PL2476685T3 (pl) Sposób wytwarzania alkilofosforanów
EP2674289A4 (en) METHOD FOR THE PRODUCTION OF TIRES
PL2694730T3 (pl) Sposób wytwarzania papieru zawierającego gips